AMLX
Price
$5.12
Change
+$0.02 (+0.39%)
Updated
Jun 3 closing price
Capitalization
456.4M
64 days until earnings call
JAZZ
Price
$110.32
Change
+$2.03 (+1.87%)
Updated
Jun 3 closing price
Capitalization
6.8B
56 days until earnings call
Interact to see
Advertisement

AMLX vs JAZZ

Header iconAMLX vs JAZZ Comparison
Open Charts AMLX vs JAZZBanner chart's image
Amylyx Pharmaceuticals
Price$5.12
Change+$0.02 (+0.39%)
Volume$1.01M
Capitalization456.4M
Jazz Pharmaceuticals
Price$110.32
Change+$2.03 (+1.87%)
Volume$702.13K
Capitalization6.8B
AMLX vs JAZZ Comparison Chart
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. JAZZ commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and JAZZ is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (AMLX: $5.12 vs. JAZZ: $110.32)
Brand notoriety: AMLX and JAZZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 103% vs. JAZZ: 55%
Market capitalization -- AMLX: $456.4M vs. JAZZ: $6.8B
AMLX [@Biotechnology] is valued at $456.4M. JAZZ’s [@Biotechnology] market capitalization is $6.8B. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileJAZZ’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • JAZZ’s FA Score: 0 green, 5 red.
According to our system of comparison, AMLX is a better buy in the long-term than JAZZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 3 TA indicator(s) are bullish while JAZZ’s TA Score has 3 bullish TA indicator(s).

  • AMLX’s TA Score: 3 bullish, 4 bearish.
  • JAZZ’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AMLX is a better buy in the short-term than JAZZ.

Price Growth

AMLX (@Biotechnology) experienced а +8.47% price change this week, while JAZZ (@Biotechnology) price change was +0.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.76%. For the same industry, the average monthly price growth was +2.77%, and the average quarterly price growth was +0.74%.

Reported Earning Dates

AMLX is expected to report earnings on Aug 07, 2025.

JAZZ is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+5.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JAZZ($6.8B) has a higher market cap than AMLX($456M). JAZZ has higher P/E ratio than AMLX: JAZZ (14.99) vs AMLX (2.69). AMLX YTD gains are higher at: 35.450 vs. JAZZ (-10.418). JAZZ has higher annual earnings (EBITDA): 1.25B vs. AMLX (-206.81M). JAZZ has more cash in the bank: 2.57B vs. AMLX (204M). AMLX has less debt than JAZZ: AMLX (1.38M) vs JAZZ (5.42B). JAZZ has higher revenues than AMLX: JAZZ (4.07B) vs AMLX (-1.27M).
AMLXJAZZAMLX / JAZZ
Capitalization456M6.8B7%
EBITDA-206.81M1.25B-17%
Gain YTD35.450-10.418-340%
P/E Ratio2.6914.9918%
Revenue-1.27M4.07B-0%
Total Cash204M2.57B8%
Total Debt1.38M5.42B0%
FUNDAMENTALS RATINGS
JAZZ: Fundamental Ratings
JAZZ
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXJAZZ
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
60%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
62%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 15 days ago
62%
Declines
ODDS (%)
Bearish Trend 8 days ago
82%
Bearish Trend 13 days ago
56%
BollingerBands
ODDS (%)
N/A
Bearish Trend 6 days ago
63%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EMF13.590.13
+0.96%
Templeton Emerging Markets Fund
BOUT35.380.21
+0.59%
Innovator IBD® Breakout Opps ETF
JHPI22.350.05
+0.24%
JHancock Preferred Income ETF
IFN16.27-0.03
-0.18%
India Fund (The)
REET24.79-0.14
-0.56%
iShares Global REIT ETF

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
+0.39%
XOMAO - AMLX
68%
Closely correlated
-0.24%
IKNA - AMLX
54%
Loosely correlated
+5.47%
XOMAP - AMLX
51%
Loosely correlated
-1.04%
RGNX - AMLX
46%
Loosely correlated
-2.13%
JAZZ - AMLX
43%
Loosely correlated
+1.87%
More